FARMACOLOGIA CLÍNICA - SUBTOMO II Introdução à Cancerologia/Oncologia JUDICIALIZAÇÃO DA SAÚDE.

quinta-feira, 9 de outubro de 2014

BIBLIOGRAFIA PARA O CAPÍTULO DO SUBTOMO III DA SÉRIE



Bibliografia.
1.            Ambrosetti A, Nadali G, Vinante F et al: Soluble interleukin-2 receptor in hairy-cell leukemia: A reliable marker of the disease. Int J Clin Lab Res 1993; 23: 34-37.
2.            Anaissie E, Kontoyiannis DP, Kantarjian H et al: Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. Ann Intern Med 1992; 117: 466-469.
3.            Agee JF, Garver FA, Faguet GB: An antigen common to chronic lymphocytic and hairy-cell leukemia cells not shared by normal lymphocytes or by other leukemic cells. Blood 1986; 68: 62-68.
4.            Antonio MA, Hawes SE, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis. 1999;180:1950-6.        
5.            Aoki H, Takishita M, Kosaka M, Saito S: Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenström’s macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter’s syndrome but not in common CLL. Blood 1995; 85: 1913-1919.
6.            Adachi M, Cossman J, Longo D et al: Variant translocation of the bcl-2 gene to immunoglobulin l light chain in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1989; 86: 2771-2774.
7.            Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. Idiosyncratic drug-induced agranulocytosis: Update of an old disorder. Eur J Intern Med 2006; 529-35.
8.            Andrew H. Fischer, Kenneth A. Jacobson, Jack Rose and Rolf Zeller; Hematoxylin and Eosin Staining of Tissue and Cell Sections; protocol was adapted from “Preparation of Cells and Tissues for Fluorescence Microscopy,” Chapter 4, in Basic Methods in Microscopy (eds. Spector and Goldman). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 2006.
9.            A.A. Smith; Specific staining of tissue components with metal–hematoxylin complexes; Micron, Volume 33, Issue 1, 2002, Pages 95–103.
10.          Anthony E. Woods; Haematoxylin and Counterstains - www.adam.com.au (em inglês).
11.          A. K. Singh, T. K. Banerjee; Recovery Of Damages In The Skin Of Arsenic Exposed Clarias batrachus (linn.) Following Withdrawal Of The Stress; Iranian Journal of Environmental Health Science & Engineering, 2008, Vol. 5, No. 4, pp. 217-224 - www.bioline.org.br (em inglês)
12.          Beaume A, Brizard A, Dreyfus B, Preud'homme JL: High incidence of serum monoclonal IgS detected by a sensitive immunoblotting technique in B-cell chronic lymphocytic leukemia. Blood 1994; 84: 1216-1219.
13.          Blattner WA, Dean JH, Fraumeni JF: Familial lymphoproliferative malignancy: clinical and laboratory follow-up. Ann Intern Med 1979; 90: 943-944.
14.          Baldini L, Cro L, Calori R et al: Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. Blood 1992; 79: 2688-2693.
15.          Bogdan C. Nitric oxide and the immune response. Nature Immunol. 2001;2:907-16.        
16.          Babula O, Lazdana G, Kroica J, Ledger WJ, Witkins SS. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis. 2003;37:733-7.
17.          Barton PT, Gerber S, Skupski DW, Witkin SS. Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal Ureaplasma urealyticum colonization in pregnant women. Infect Immun. 2003;71:271-4.
18.          Boxer LA. Leucopenia. In: Kliegman RM, Berhman RF, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders; 2007. p.909-15.        
19.          Berliner N. Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis. Blood 2008; 111:5427-32.        
20.          Boxer LA. Neutrophil abnormalities. Pediatr Rev 2003; 24:52-62.        
21.          Boxer LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer 2007;49:609-14.        
22.          Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998; 91:181-6.
23.          Brown AG, Ross FM, Dunne EM et al: Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nature Genetics 1993; 3: 67-72.
24.          Bullrich F, Veronese ML, Kitada S et al: Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 1996; 88: 3109-3115.
25.          Bernard SM, Cartwright RA, Bird CC et al: Aetiologic factors in lymphoid malignancies: a case control epidemiological study. Leukemia Res 1984; 8: 681-689.
26.          Bonvalet D, Foldes C, Civatte J: Cutaneous manifestations in chronic lymphocytic leukemia. J Dermatol Surg Oncol 1984; 10: 278-282.
27.          Bastion Y, Coiffier B, Dumontet C et al: Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Ann Oncol 1992; 3: 171-173.
28.          Briz M, Cabrera R, Sanjuán I et al: Diagnosis of transfusion-associated graft versus-host disease by polymerase chain reaction in fludarabine-treated B-chronic lymphocytic leukaemia. Br J Haematol 1995; 91: 409-411.
29.          Brunning RD: T-prolymphocytic leukemia. Blood 1991; 78: 3111-3113.
30.          Bosch F, Campo E, Jares P et al: Increased expression of the PRAD-1/ CCND1 gene in hairy cell leukaemia. Br J Haematol 1995; 91: 1025-1030.
31.          Bain BJ, Catovsky D: The leukaemic phase of non-Hodgkin's lymphoma. J Clin Pathol 1995; 48: 189-193.
32.          Bosch F, Jares P, Campo E et al: PRAD-1/CYCLIN D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific markers of mantle cell lymphoma. Blood 1994; 84: 2726-2732.
33.          Bouroncle BA, Wiseman BK, Doak CA: Leukemic reticuloendotheliosis. Blood 1958; 13: 609-629.
34.          Bosch F, Campo E, Jares P et al: Increased expression of the PRAD-1/ CCND1 gene in hairy cell leukaemia. Br J Haematol 1995; 91: 1025-1030.
35.          Bible KC, Tefferi A: Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis. Br J Haematol 1996; 93: 406-408.
36.          Borg A, Yin JA, Johnson PR et al: Successful treatment of HTLV-I associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. Br J Haematol 1996; 94: 713-715.
37.          Brouet JCV, Fermand JP, Laurent G et al: The association of chronic lymphocytic leukaemia and multiple myeloma: A study of eleven patients. Br J Haematol 1985; 59: 55-66.
38.          Criel A, Wlodarska I, Meeus P et al: Trisomy 12 is uncommon in typical chronic lymphocytic leukemias. Br J Haematol 1994; 87: 523-528.
39.          Chapman RM, Corcoran MM, Gardiner A et al: Frequent homozygous deletions of the D13S25 locus in chromosome region 13q14 defines the location of a gene critical in leukemogenesis in chronic lymphocytic leukemia. Oncogene 1994; 9: 1289-.
40.          Cuttner J: Increased incidence of hematologic malignancies in first-degree relatives of patients with chronic lymphocytic leukemia. Cancer Invest 1992; 10: 103-109.
41.          Caligaris-Cappio F: B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood 1996; 87: 2615-2620.
42.          Cheson BD: Chronic lymphocytic leukemia and hairy-cell leukemia. Curr Opin Haematol 1994; 1: 268-277 & B91-B93.
43.          Células Sangüíneas - Um Guia Prático.
Autor: Bain, Barbara J.
Editora: Artmed.
44.          Corpo Humano - Sistema Circulatório.
Autor: Ferrari, Elizabeth Ávila.
Editora: Todolivro.
45.          Campisi J, Leem TH, Fleshner M. Stress-induced extracellular hsp72 is a functionally significant danger signal to the immune system. Cell Stress Chaperones. 2003;8:272-86.
46.          Carl M. Johnson; A Rapid Technique for Iron-Hematoxylin Staining Requiring No Microscopic Control of Decolorization; Am J Trop Med Hyg September 1935 s1-15:551-553.
47.          Cláudio S. Ferreira; TECHNICAL REPORT - STAINING OF INTESTINAL PROTOZOA WITH HEIDENHAIN’S IRON HEMATOXYLIN; Rev. Inst. Med. trop. S. Paulo, 45(1):43-44, January-February, 2003.
48.          Dameshek W: Chronic lymphocytic leukemia - an accumulative disease of immunologically incompetent lymphocytes. Blood 1967; 29: 566-584.
49.          Dallman PR. Blood and blood-forming tissues. In: Rudolph AM, editors. Rudolph’s pediatrics. 16th ed. New York: Appleton-Century-Crofts; 1977. p.1178.        
50.          Dinauer MC. The phagocyte system and disorders of granulopoiesis and granulocyte function. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski’s hematology of infancy and childhood. 6th ed. Philadelphia: Saunders; 2003. p.923-1010.
51.          Eschenbach DA, Thwinn SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, et al. Influence of the normal menstrual cycle on vaginal tissue, discharge and microflora. Clin Infect Dis. 2000;30:901-7.        
52.          Eschenbach DA, Patton DL, Hooten TM, Meier AS, Stapleton A, Aura J, et al. Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium. J Infect Dis. 2001;183:913-8.        
53.          FAILACE R., Hemograma, Manual de Interpretação; Artmed; quarta edição, ISBN 85-363-0158-9
54.          Finch SC, Linet MS: Chronic leukaemias. Baillière's Clin Haematol 1992; 5: 27-56.
55.          Fegan C, Robinson H, Thompson P et al: Karyotypic evolution in CLL: identification of a new subgroup of patients with deletions of 11q and advanced or progressive disease. Leukemia 1995; 9: 2003-2008.
56.          Faguet GB: Chronic lymphocytic leukemia: an updated review. J Clin Oncol 1994; 12: 1974-1990.
57.          Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353:1899-911. 
58.          Fiscella K, Klebanoff MA. Are racial differences in vaginal pH explained by vaginal flora? Am J Obstet Gynecol. 2004;191:747-50.
59.          Favara, B.E., Jaffe, R.: The histopathology of Langerhans cell histiocytosis. Br J Cancer 1994; 70 ( Suppl.): 17-23.
60.          Feldman, R.B., Moore, D.m., Hood, C.I.: Solitary eosinophilic granuloma of the lateral wall. Am J Ophthalmn. 1985 Aug 15;100: 318-323.
61.          Genc MR, Vardhana S, Delaney MI, Onderdonk A, Tuomala R, Norwitz E, et al. Relationship between a Toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol. 2004;116:152-6.        
62.          Giraldo P, Neuer, Ribeiro-Filho A, Linhares I, Witkin SS. Detection of the human 70-kD and 60-kD heat shock proteins in the vagina: relation to microbial flora, vaginal pH, and method of contraception. Infect Dis Obstet Gynecol. 1999;7:23-5.        
63.          Giraldo P, Neuer A, Korneeva IL, Ribeiro-Filho A, Simões JA, Witkin SS. Vaginal heat shock protein expression in symptom-free women with a history of recurrent vulvovaginitis. Am J Obstet Gynecol. 1999;180:524-9.         
64.          Galas, D. J., & Hood, L.. (2009). "Systems Biology and Emerging Technologies Will Catalyze the Transition from Reactive Medicine to Predictive, Personalized, Preventive and Participatory (P4) Medicine". Interdisciplinary Bio Central 1: 1–4. DOI:10.4051/ibc.2009.2.0006.
65.          Genc MR, Delaney ML, Onderdonk AB, Witkin SS. Vaginal nitric oxide in pregnant women with bacterial vaginosis. Am J Reprod Immunol .2006;56:86-90.        
66.          Ghosh M, Shen Z, Schaefer TM, Fahay JV, Gupta P, Wira CR. CCL20'MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol. 2009;62:60-71.
67.          Galton DAG: The pathogenesis of chronic lymphocytic leukemia. Can Med Assoc J 1966; 94: 1005-1010.
68.          Gale RP, Caligaris-Cappio F, Dighiero G et al (International Workshop on Chronic Lymphocytic Leukemia): Recent progress in chronic lymphocytic leukemia. Leukemia 1994; 8: 1610-1614.
69.          Ho C-H, Chiang Y-M, Chong L-L et al: Development of chronic lymphocytic leukaemia in a case of Sjögren's syndrome with systemic lupus erythematosus. Scand J Haematol 1985; 35: 246-248.
70.          Haubenstock A, Zalusky R: Autoimmune hyperthyroidism and thrombocytopenia developing in a patient with chronic lymphocytic leukemia. Am J Hematol 1985; 19: 281-283.
71.          Hancock REW. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis. 2000;1:156-64.   
72.          Han JH, Kim MS, Lee MY, Lee MK, Kim RH, Myung SC. Modulation of human b-defensin-e expression by 17b-estradiol and progesterone in vaginal epithelial cells. Cytokyne. 2010;49:209-14.        
73.          Hollander AAMJ, Kluin-Nelemans HC et al: Correction of neutropenia associated with chronic lymphocytic leukemia following treatment with granulocyte-macrophage colony-stimulating factor. Ann Hematol 1991; 62: 32-34.
74.          http://es.wikipedia.org/wiki/Leucemia
75.          http://www.fcarreras.org/es/pacientes_191
76.          http://www.cancer.gov/diccionario/?CdrID=45164
77.          http://www.cancer.gov/diccionario/?CdrID=46278
78.          http://www.dmedicina.com/enfermedades/cancer/leucemia
79.          http://www.esmas.com/salud/enfermedades/cronicas/371310.html
80.          http://www.fcarreras.org/es/diagn%C3%B3stico_1797
81.          Ho AD, Thaler J, Stryckmans P et al: Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer. J Natl Cancer Inst 1990; 82: 1416-1420.
82.          HISTOLOGIA BÁSICA 10.a ed.  Junqueira & Carneiro, Ed. Guanabara Koogan.
83.          http://www.multipolo.com.br/histologia
84.          http://www.virtual.epm.br/material/histologia/frame.htm
85.          http://open-site.org/Science/Biology/Histology/
86.          http://wberesford.hsc.wvu.edu/histol.htm#HISTOLOGY:%20METHOD%20AND%20MICROSCOPY
87.          Jouve, L., Bollini, G., Jacquemier, M., Bouyala, J.M.: 15 cases of vertebral involvement of histiocytosis X in children. Review of the literature. Ann Pediatr Paris 1991; 38: 167-174.
88.          JANEWAY, Charles; Paul Travers, Mark Walport, and Mark Shlomchik. Immunobiology; Fifth Edition. New York and London: Garland Science, 2001. ISBN 0-8153-4101-6.
89.          Lymphatic System Overview (innerbody.com)
90.          Lyall EGH, Lucas GF, Eden OB. Autoimmune neutropenia of infancy. J Clin Pathol 1992; 45:431-4.        
91.          Larsen B, Monif GRG. Understanding the bacterial flora of the female genital tract. Clin Infect Dis. 2001;32: e69-77.
92.          Laurence A, Chowdary P, Ancliff P. Disorders of granulopoiesis and granulocyte function. In Arceci RJ, Han IM, Owen PS, editors. Pediatric Hematology. 3rd ed. Oxford: Blackwell Publishing; 2006. p.305-39.        
93.          Limon J, Nedoszytko B, BrozeI et al: Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sézary syndrome. Cancer Genet Cytogenet 1995; 83: 75-81.
94.          Lorincz A: Cutaneous T-cell lymphoma (mycosis fungoides). Lancet 1996; 347: 871-876.
95.          Loughran ThP Jr: Clonal diseases of large granular lymphocytes. Blood 1993; 82: 1-14.
96.          Iida S, Rao P, Nallasivam P et al: The t(9;14)(q13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves de PAX-5 gene. Blood 1996; 88: 4110-4117.
97.          Levy R: Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 1993; 362: 755-758.
98.          Lunardi, P.. Farah, J.O., Qhaso, R., et al.: Primary eosinophilic granuloma invading the skull base: case report and critical review of the literature. Tumori 1996; 82: 397-400.
99.          Mayer P. Ueber das Färben mit Hämatoxylin. Mitt Zool Stat Neapel 1891;10:170-86.
100.       Mestecky J, Russell MW. Induction of mucosal immune responses in the human.        
101.       Matutes E, Brito-Babapulle V, Swansbury J et al: Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78: 3269-3274.
102.       Novak RM, Donoval BA, Graham PJ, Boksa LA, Spear G, Hershow RC,et al. Cervicovaginal lavels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginosis in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol. 2007;14:1102-7.
103.       Nishiyama H, Mokuno J, Inoue T: Relative frequency and mortality rate of various types of leukemia in Japan. Jap J Cancer Res 1969; 60: 71-81.
104.       Nauert, C., Zornoza, J., Ayala, A., Harle, T.S.: Eosinophilic granuloma of the jaw: diagnosis and management. Skeletal Radiol 1983; 10: 227-235.  
105.       Nowell PC, Moreau L, Growney P, Besa EC: Karyotypic stability in chronic B-cell leukaemia. Cancer Genet Cytogenet 1988; 33: 155-160.
106.       Neuland CY, Blattner, Mann DL et al: Familial chronic lymphocytic leukemia. J Natl Cancer Inst 1983; 71: 1143-1150.
107.       Pinto A, Vecchio LD, Carbone A et al: Expression of myelomonocytic antigens is associated with unfavorable clinico-prognostic factors in B-cell chronic lymphocytic leukemia. Ann Oncol 1991; 2: 107-113.
108.       Polliack A, Rabinowitz R, Leizerowitz R et al: Myelomonocytic antigens are rarely expressed on B-lymphocytic leukemia cells. Leuk Lymphoma 1993; 9: 125-131.
109.       Pérez Losada A, Wessman M, Tiainen M et al: Trisomy 12 in chronic lymphocytic leukemia: An interphase cytogenetic study. Blood 1991; 78: 775-779.
110.       Pangalis GA, Moutsdopoulos HM, Papadopoulos NM et al: Monoclonal and oligoclonal immunoglobulins in the serum of patients with B-chronic lymphocytic leukemia. Acta Haematol 1988; 80: 23-27.
111.       Papadaki HA. Chronic idiopathic neutropenia: clinical and pathophysiological aspects. Hematology Education: the education program for the annual congress of the European Hematology Association 2008; 2:255-61.        
112.       Pavlova SI, Kilic SS, So JS, So JS, Nader-Macias ME, Simoes JA, et al. Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J Appl Microbiol. 2002;92:451-9.        
113.       Pillay K, Coutsoudis A, Agadzi-Naqvi AK, Kuhn L, Coovadia HM, Janoff EN, et al. Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Infect Dis. 2001;183:653-6.
114.       Priestlley CFJ, Jones BM, Dhar J, Goodwin L. What is normal vaginal flora? Genitourin Med.1997;73:23-8.
115.       Levinson, Samuel A.; MacFate, Robert P. - Clinical Laboratory Diagnosis. 7th edition, Philadelphia, Lea & Febiger, 1969, 1323 pp.
116.       Lendrum AC, Mc17arlane D. A controllable modification of Mallory's trichromic staining method. J Pathol Bact 1940;50:381-
117.       Qualye AJ. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol. 2002;57:61-79.        
118.       Resnitzky P, Matutes E, Hedges M et al: The ultraestructure of mantle-cell lymphoma and other B-cell disorders with translocation t(11;14)(q13;q32). Br J Haematol 1996; 94: 352-361.
119.       Rozman M, Bosch F, Villamor N et al: Mantle-cell lymphoma (MCL) in leukemic phase ("MC leukemia"): A study of 14 cases. Blood, 1996; 88 (suppl 1): 225a, abstract no. 888.
120.       Resing-Ehl A, Ehl S. Autoimmune neutropenia. Hematology Education: the education program for the annual congress of the European Hematology Association 2008; 2:248-54.        
121.       Rodriguez JM, Collins MD, Sjoden B, Falsen E. Characterization of a novel Atopobium isolate from the human vagina: description of Atopobium vaginae sp. nov. Int J Syst Bacteriol. 1999;49:1573-6.        
122.       Royce RA, Jackson TP, Thorp JMJ, Hillier SL, Rabe LK, Pastore LM, et al. Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis. 1999;26:96-102.        
123.       Rai KR, Peterson B, Elias L et al: A ramdomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C and ECOG inter-group study (Abstract). Blood 1996; 88 (suppl 1): 141a.
124.       Reinisch W, Willheim M, Hilgarth M et al: Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. J Clin Oncol 1994; 12: 2146-2152.
125.       Rozman C (editor): Chronic lymphocytic leukaemia and related disorders. Baillière's Clin Haematol 1993; 6: 757-919.
126.       Rozman C, Montserrat E, Viñolas N: Serum immunoglobulins in B-chronic lymphocytic leukaemia. Natural history and prognostic significance. Cancer 1988; 61: 279-283.
127.       Richter MN: Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukaemia. Am J Pathol 1928; 4: 285-292.
128.       Robertson LE, Pugh W, O'Brien S et al: Richter's syndrome: a report on 39 patients. J Clin Oncol 1993; 11: 1985-1989.
129.       R. W. Sabnis; Handbook of Biological Dyes and Stains: Synthesis and Industrial Applications; John Wiley & Sons, 2010. 544 páginas
130.       Ribera JM, Viñolas N, Urbano Ispízua A et al: "Spontaneous" complete remissions in chronic lymphocytic leukemia: report of three cases and review of the literature. Blood Cells 1987; 12: 471-479.
131.       Rozman C, Montserrat E: Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052-1057.
132.       Riddell S, Johnston JB, Bowman D et al: 2-deoxycoformycin (DCF) in chronic lymphocytic leukemia (CLL) and Waldenström's macroglobulinemia (abstract). Proc ASCO 1985; p:167.
133.       Rosen ST, Foss FM: Chemotherapy for mycosis fungoides and the Sézary syndrome. Hematol Oncol Clin North Am 1995; 9: 1109-1116.
134.       Shastry BS. (2006). "Pharmacogenetics and the concept of individualized medicine". Pharmacogenomics J. 6 (1): 16–21. DOI:10.1038/sj.tpj.6500338. PMID 16302022.
135.       Sasson, Sezar; Silva Junior, Cesar da - Biologia 1 Citologia Histologia - 5ª Edição - Atual Editora, São Paulo, 1989 - ISBN 85-7056-045-1
136.       Swidsinski A, Mendling W, Loening-Baucke V, Ladhoff A, Swidsinski S, Hale LP, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol. 2005;106:1013-23.         
137.       Schwebke JR, Richey CM, Weiss HL. Correlation of behaviors with microbiologic changes in vaginal flora. J Infect Dis 1999;180:1632-6.
138.       Stevens-Simon C, Jamison J, McGregor JA, Douglas JM. Racial variation in vaginal pH among healthy sexually active adolescents. Sex Transm Dis. 1994;21:168-72.  
139.       Stevens RF. Disorders of granulopoiese and granulocyte function. In Lilleyman JS, Hann IM, Blanchette VS, editors. Pediatric Hematology. 2nd ed. London: Harcourt Brace and Company; 1999. p.331-53.
140.       Segel GB, Halterman JS. Neutropenia in pediatric pratice. Pediatr Rev 2008; 29:12-24.
141.       Subramanian, N., Krishnakumar, S., Babu, K., Mohan, R., Lakshmi, K.S., Biswas, J.: Adult onset Langerhans cell histiocytosis of the orbit--a case report. Orbit. 2004; 23: 99-103.
142.       Types of Oncologists". Cancer.Net : American Society of Clinical Oncology (ASCO). Retrieved 25 May 2013.
143.       Temas: Medicina, Anatomia, Saúde
Você e seu sangue.
Autor: Bernardes, Heloisa.
Editora: HLB.
144.       Temas: Medicina, Anatomia, Saúde
O sangue nas doenças sistêmicas.
Autor: Greaves, Michael..
Editora: Manole.
145.       Temas: Medicina, Anatomia, Hematologia
Técnicas modernas em banco de sangue e transfusão.
Autor: Figueiredo, José Eduardo Ferreira de
Editora: Revinter
146.       Temas: Medicina, Anatomia, Hematologia
Você e seu Sangue
Autor: Bernardes, Heloisa Leoni
Editora: Hlb Editora
147.       Técnicas Modernas em Banco de Sangue e Transfusão
Autor: Harmening, Denise M.
Editora: Revinter
148.       Técnicas Modernas em Banco de Sangue e Transfusão.
A Resposta Está no Sangue
Autor: Stevens, Neil Editora: Isis
149.       The Lymphatic System (MedicalEngineer.co.uk)
150.       Técnicas Modernas em Banco de Sangue e Transfusão
Abc da Química Ácido - Básica do Sangue.
Autor: Davenport, Horace W.
Editora: Atheneu SP.
151.       Técnicas Modernas em Banco de Sangue e Transfusão
Leucemias & Linfomas - Atlas do Sangue Periférico.
Autor: Melo, Marcio.
Editora: Livraria Médica Paulista – Lmp.
152.       Técnicas Modernas em Banco de Sangue e Transfusão
Manual de Transfusão de Sangue.
Autor: Chamone, Dalton de A. F.
Editora: Roca-Brasil.
153.       Técnicas Modernas em Banco de Sangue e Transfusão
O Sangue nas Doenças Sistêmicas.
Autor: Markis, Michael.
Editora: Manole.
154.       Técnicas Modernas em Banco de Sangue e Transfusão
Por dentro do Sistema Imunológico.
Autor: Cunha, Paulo.
Editora: Atual.
155.       Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol. 2002;14:103-10.   
156.       Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Delanghe J, Van Simaey L, et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atobobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiology. 2004;4:16-26.        
157.       Voellmy R. The stress protein response: consequences of stress exposurecytoprotection-potential diagnostic and therapeutic applications. Methods. 2005;35:115-6.        
158.       Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology. 2004;150: 2565-73.        
159.       Woessner S, Asensio A, Florensa L et al:: Expression of lymphocyte function-associated antigen (LFA)-1 in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 1994; 13: 457-461.
160.       Wulf G, Kluding H, Ho AD et al: Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern Blot analysis. Leuk Res 1994; 18: 475-484.
161.       Woo, K.I., Harris, J.G.: Eosinophilic granuloma of the orbit: understanding the paradox of aggressive destruction responsive to minimal intervention. Ophthal Plast Reconstr Surg. 2003; 19: 453-455.  
162.       Woessner S, Solé F, Pérez-Losada A et al: Trisomy 12 is a rare cytogenetic finding in typical chronic lymphocytic leukemia. Leuk Res 1996; 20: 369-374.
163.       Weeks JC, Tierney MR, Weinstein MC: Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med 1991; 325: 81-86.
164.       W. C. Barrett; Heidenhain's Hematoxylin Used with the Smear Technic; Biology Institute, Harvard University, Cambridge, Mass 1932, Vol. 7, No. 2, Pages 63-64.
165.       Weisenburger D, Armitage JO: Mantle cell lymphoma: an entity comes of age. Blood 1996; 87: 4483-4494.
166.       Witkin SS. Immunology of recurrent vaginitis. Am J Reprod Immunol Microbiol. 1987;15:34-7.        
167.       King AE, Wheelhouse N, Cameron S, McDonald SE, Lee FK, Entrican G, et al. Expression of secretory leukocyte protease inhibitor and elafin in human fallopian tube and in an in-vitro model of Chlamydia trachomatis infection. Hum Reprod. 2009;24:679-86. 
168.       Klein NJ. Mannose-binding lectin: do we need it? Mol Immunol. 2005;42:919-24.        
169.       Kuzel TM, Roenigk HH Jr, Samuelson E et al: Effectiveness of interferon alfa-2a combined with phothotherapy for mycosis fungoides and the Sézary syndrome. J Clin Oncol 1995; 13: 257-263.
170.       Kuzel TM, Hurria A, Samuelson E et al: Phase II trial of 2-chlorodeoxyadenosine for the treatmet of cutaneous T-cell lymphoma. Blood 1996; 87: 906-911.
171.       Kim YH, Bishop K, Varghese A, Hoppe RT: Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. Arch Dermatol 1995; 131: 1003-1008.

Nenhum comentário:

Postar um comentário